Alpha 2.0

» Articles » PMID: 37660053

Association Between 5-year Change in Cardiovascular Risk and the Incidence of Atherosclerotic Cardiovascular Diseases: a Multi-cohort Study

Overview

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2023 Sep 2

PMID 37660053

Authors

Authors

Jiayi Yi

Lili Wang

Xinli Guo

Xiangpeng Ren

Affiliations

Affiliations

Soon will be listed here.

Abstract

Background: The influence of the historical cardiovascular risk status on future risk of atherosclerotic cardiovascular disease (ASCVD) is poorly understood. We aimed to investigate the association between 5-year changes in cardiovascular risk and ASCVD incidence.

Methods: We analyzed pooled data from seven community-based prospective cohort studies with up to 20 years of follow-up data. The study populations included White or Black participants aged 40-75 years without prevalent ASCVD. Cardiovascular risk was assessed using the pooled cohort equation and was categorized into non-high (< 20%) or high risk (≥ 20%). Changes in cardiovascular disease (CVD) risk over a 5-year interval were recorded. The main outcome was incident ASCVD.

Results: Among 11,026 participants (mean [SD] age, 60.0 [8.1] years), 4272 (38.7%) were female and 3127 (28.4%) were Black. During a median follow-up period of 9.9 years, 2560 (23.2%) ASCVD events occurred. In comparison with individuals showing a consistently high CVD risk, participants whose CVD risk changed from non-high to high (hazard ratio [HR], 0.67; 95% confidence interval [CI] 0.59-0.77) or high to non-high (HR, 0.57; 95% CI 0.41-0.80) and those with a consistently non-high risk (HR, 0.33; 95% CI 0.29-0.37) had a lower risk of incident ASCVD. In comparison with individuals showing a consistently non-high CVD risk, participants whose CVD risk changed from high to non-high (HR, 1.74; 95% CI 1.26-2.41) or from non-high to high risk (HR, 2.04; 95% CI 1.84-2.27) and those with a consistently high risk (HR 3.03; 95% CI 2.69-3.42) also showed an increased risk of incident ASCVD.

Conclusions: Individuals with the same current CVD risk status but different historical CVD risks exhibited varying risks of future ASCVD incidents. Dynamic risk evaluation may enable more accurate cardiovascular risk stratification, and decision-making regarding preventive interventions should take the historical risk status into account.

Citing Articles

Insulin resistance assessed by estimated glucose disposal rate and risk of atherosclerotic cardiovascular diseases incidence: the multi-ethnic study of atherosclerosis.

Yi J, Qu C, Li X, Gao H Cardiovasc Diabetol. 2024; 23(1):349.

PMID: 39342205 PMC: 11439291. DOI: 10.1186/s12933-024-02437-2.

References

1.

. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989; 129(4):687-702. View

2.

Bibbins-Domingo K, C Grossman D, Curry S, Davidson K, Epling Jr J, Garcia F . Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 316(19):1997-2007. DOI: 10.1001/jama.2016.15450. View

3.

Doll R, Peto R, Boreham J, Sutherland I . Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004; 328(7455):1519. PMC: 437139. DOI: 10.1136/bmj.38142.554479.AE. View

4.

Arnett D, Blumenthal R, Albert M, Buroker A, Goldberger Z, Hahn E . 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140(11):e563-e595. PMC: 8351755. DOI: 10.1161/CIR.0000000000000677. View

5.

Huang Z, Chen Z, Wang X, Ding X, Cai Z, Li W . Association of Cardiovascular Health Score Trajectory With Incident Myocardial Infarction in Hypertensive Patients. Hypertension. 2022; 79(11):2622-2630. DOI: 10.1161/HYPERTENSIONAHA.122.19633. View

6.

Ferket B, van Kempen B, Heeringa J, Spronk S, Fleischmann K, Nijhuis R . Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling study. PLoS Med. 2013; 9(12):e1001361. PMC: 3531501. DOI: 10.1371/journal.pmed.1001361. View

7.

Yi J, Wang L, Guo X, Ren X . Association of Life's Essential 8 with all-cause and cardiovascular mortality among US adults: A prospective cohort study from the NHANES 2005-2014. Nutr Metab Cardiovasc Dis. 2023; 33(6):1134-1143. DOI: 10.1016/j.numecd.2023.01.021. View

8.

Kishi S, Teixido-Tura G, Ning H, Ambale Venkatesh B, Wu C, Almeida A . Cumulative Blood Pressure in Early Adulthood and Cardiac Dysfunction in Middle Age: The CARDIA Study. J Am Coll Cardiol. 2015; 65(25):2679-87. DOI: 10.1016/j.jacc.2015.04.042. View

9.

Tsao C, Vasan R . Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol. 2015; 44(6):1800-13. PMC: 5156338. DOI: 10.1093/ije/dyv337. View

10.

van Sloten T, Tafflet M, Perier M, Dugravot A, Climie R, Singh-Manoux A . Association of Change in Cardiovascular Risk Factors With Incident Cardiovascular Events. JAMA. 2018; 320(17):1793-1804. PMC: 6248104. DOI: 10.1001/jama.2018.16975. View

11.

Fried L, Borhani N, Enright P, Furberg C, Gardin J, Kronmal R . The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991; 1(3):263-76. DOI: 10.1016/1047-2797(91)90005-w. View

12.

Lim G . Reductions in LDL-cholesterol and blood-pressure levels have cumulative benefits. Nat Rev Cardiol. 2019; 16(11):650. DOI: 10.1038/s41569-019-0279-x. View

13.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7. DOI: 10.1016/S0140-6736(07)61602-X. View

14.

. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20(7):1183-97. DOI: 10.2337/diacare.20.7.1183. View

15.

Goff Jr D, Lloyd-Jones D, Bennett G, Coady S, DAgostino R, Gibbons R . 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 129(25 Suppl 2):S49-73. DOI: 10.1161/01.cir.0000437741.48606.98. View

16.

Shah N, Lloyd-Jones D, Oflaherty M, Capewell S, Kershaw K, Carnethon M . Trends in Cardiometabolic Mortality in the United States, 1999-2017. JAMA. 2019; 322(8):780-782. PMC: 6714016. DOI: 10.1001/jama.2019.9161. View

17.

. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1789-1858. PMC: 6227754. DOI: 10.1016/S0140-6736(18)32279-7. View

18.

Bild D, Bluemke D, Burke G, Detrano R, Diez Roux A, Folsom A . Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002; 156(9):871-81. DOI: 10.1093/aje/kwf113. View

19.

Chung R, Mackie A, Baker A, de Ferranti S . Cardiovascular Risk and Cardiovascular Health Behaviours in the Transition From Childhood to Adulthood. Can J Cardiol. 2020; 36(9):1448-1457. DOI: 10.1016/j.cjca.2020.05.041. View

20.

Wyatt S, Diekelmann N, Henderson F, Andrew M, Billingsley G, Felder S . A community-driven model of research participation: the Jackson Heart Study Participant Recruitment and Retention Study. Ethn Dis. 2003; 13(4):438-55. View